MedTrace Logo

Blue Light Cystoscopy With Cysview® Registry

NCT02660645 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4400

Last updated 2025-12-18

No results posted yet for this study

Summary

Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.

Conditions

Interventions

DRUG

Hexaminolevulinate hydrochloride (HCL)

Instillation in bladder

DEVICE

Karl Storz D-Light C Photodynamic Diagnostic (PDD) system

Cystoscopy procedure

Sponsors & Collaborators

  • Catalyst Pharmaceutical Research

    collaborator INDUSTRY

  • Photocure

    lead INDUSTRY

Principal Investigators

  • Siamak Daneshmand, MD · University of Southern California

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02660645 on ClinicalTrials.gov